Humana Inc. HUM
397.93
17.61
4.63%
as of 25 Sep
- Market cap
- $45.7B
- P/E
- 37.4×
Follow HUM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Humana Inc. (HUM) EV/EBITDA
As of 25 September 2026, Humana Inc. (HUM) trades at a EV/EBITDA of 10.9×. Over the past ten years it has ranged from 3.6× (March 2026) to 15.9× (December 2021); the current reading is higher than 86% of that period. That is in line with the Healthcare Plans industry median of 10.9× and in line with the Healthcare sector median of 10.4×.
EV/EBITDA, daily
Annual
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 6.8× | 9.29% |
| FY2024 | 6.2× | (37.09%) |
| FY2023 | 9.9× | (17.49%) |
| FY2022 | 11.9× | (17.10%) |
| FY2021 | 14.4× | 84.73% |
| FY2020 | 7.8× | (26.17%) |
| FY2019 | 10.6× | 15.97% |
| FY2018 | 9.1× | 56.14% |
| FY2017 | 5.8× | (41.89%) |
| FY2016 | 10.0× | 33.94% |
Quarterly
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 10.9× | 175.04% |
| Mar 2026 | 4.0× | (41.38%) |
| Dec 2025 | 6.8× | 16.33% |
| Sep 2025 | 5.8× | 17.03% |
| 42 more quarters | Free account |
Against its own ten years
Low 3.6×
High 15.9×
Ten-year median
7.6×
Current reading's percentile
86
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| CNC Centene Corporation compare | n/m |
| CI Cigna Group compare | 7.7× |
| OSCR Oscar Health, Inc. compare | 8.4× |
| CVS CVS Health Corporation compare | 8.7× |
| ELV Elevance Health, Inc. compare | 9.0× |
| HUM Humana Inc. | 10.9× |
| MOH Molina Healthcare, Inc compare | 13.0× |
| UNH UnitedHealth Group Incorporated compare | 14.5× |
| Healthcare Plans industry median | 10.9× |
| Healthcare sector median | 10.4× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on HUM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement